Craniofacial anomalies (CFAs) are the most frequently occurring human congenital disease, and a major cause of infant mortality and childhood morbidity. Although CFAs seems to arise from a combination of genetic factors and environmental influences, the underlying gene defects and pathophysiological mechanisms for most CFAs are currently unknown. Here we reveal a role for the E3 ubiquitin ligase Wwp2 in regulating craniofacial patterning. Mice deficient in Wwp2 develop malformations of the craniofacial region. Wwp2 is present in cartilage where its expression is controlled by Sox9. Our studies demonstrate that Wwp2 influences craniofacial patterning through its interactions with Goosecoid (Gsc), a paired-like homeobox transcription factor that has an important role in craniofacial development. We show that Wwp2-associated Gsc is a transcriptional activator of the key cartilage regulatory protein Sox6. Wwp2 interacts with Gsc to facilitate its monoubiquitylation, a post-translational modification required for optimal transcriptional activation of Gsc. Our results identify for the first time a physiological pathway regulated by Wwp2 in vivo, and also a unique non-proteolytic mechanism through which Wwp2 controls craniofacial development.
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Ubiquitin is an important post-translational modifier, with profound effects on various aspects of protein biology by altering turnover rate, subcellular localization and/or activity of target proteins 1, 2 . Ubiquitin is conjugated to target proteins through an enzymatic process mediated by E3 ubiquitin ligases, such as Wwp2. As a member of the Nedd4-family of E3 ligases, Wwp2 contains an amino-terminal C2 domain, a WW domain, and a carboxy-terminal catalytic HECT domain 3 . The HECT domain of Wwp2 contains an active Cys residue that mediates ubiquitin transfer from E2 enzymes to itself, and then to target proteins. Wwp2 can facilitate conjugation of ubiquitin to several proteins in vitro [4] [5] [6] . However, the in vivo function of Wwp2 is currently unknown. This is generally true of most members of the mammalian Nedd4 family of E3 ligases, as several studies have demonstrated key roles for these proteins in regulating specific signalling pathways in vitro, yet there is a dearth of in vivo data to indicate that they regulate specific physiological processes. Therefore, demonstrating that Wwp2 has a role in vivo would aid in confirming the biological relevance of the Nedd4 family of E3 ubiquitin ligases.
To identify physiological processes regulated by Wwp2, we generated mice deficient in Wwp2. We used gene-trap technology to generate Wwp2-null mice using embryonic stem cells that contain the bacterial β-galactosidase (LacZ) gene inserted into intron 3-4 of the Wwp2 locus ( Fig. 1a ). Insertion of LacZ at this location resulted in complete ablation of Wwp2 transcript and protein levels in mice homozygous for the gene-trapped allele (Wwp2 Gt/Gt ; Fig. 1b, c) . Analysis of litters born to male and female mice heterozygous for the Wwp2 gene trap allele (Wwp2 Gt/+ ) revealed that mature Wwp2 Gt/Gt mice are runted when compared with age and sex-matched wild-type controls ( Fig. 1d, e ). Wwp2 Gt/Gt mice show abnormal craniofacial development that is characterized by the presence of a domed skull and a shortened snout ( Fig. 1f ). Although we observed 100% penetrance in the development of craniofacial abnormalities in Wwp2 Gt/Gt mice, the severity of the phenotype was variable. A subset of Wwp2 Gt/Gt mice developed a more profound craniofacial malformation characterized by a misaligned jaw and a twisted snout ( Fig. 1g ). Misalignment of the jaw in the Wwp2 Gt/Gt mice resulted in chronic overgrowth of the mandibular incisors ( Fig. 1g ). To further quantify the craniofacial abnormalities, we used quantitative computed tomography (μ-QCT) to scan the skulls of the Wwp2 Gt/Gt and wild-type mice. The nasal bones of Wwp2 Gt/Gt mice were decreased in length by 20% and were twisted by 10-25° in mice with the more severe asymmetric nasal bone phenotype (Fig. 1h, i) .
The Wwp2 gene-trap allele allows LacZ to be expressed from the endogenous Wwp2 locus (Fig. 1a ). Thus LacZ can be used as a surrogate marker to track Wwp2 expression in vivo. Staining of whole-mount skulls isolated from wild-type and Wwp2 Gt/Gt neonatal mice revealed that LacZ was present in the nasofrontal region of the skull, which is consistent with the type of craniofacial abnormalities observed in Wwp2 Gt/Gt mice ( Fig. 2a ). Further immunostaining analysis of wild-type and Wwp2 Gt/Gt skulls using an anti-X-gal antibody revealed specific LacZ-staining patterns in regions of the skull that were also positive for Safranin O, a stain used to detect cartilage proteoglycans ( Fig. 2b, c ). Serial histological sections of wild-type skulls were analysed by in situ hybridization for the expression of Wwp2 and immunostaining for Sox9. At various stages of development, Wwp2 could be detected in cartilaginous regions of the skull that were also positive for Sox9, demonstrating that Wwp2 expression in cartilage is necessary for proper patterning of the craniofacial region of the skull ( Fig. 2d , e; Supplementary Information, Fig. S1 ).
On the basis of the restricted pattern of Wwp2 expression in cartilage, we hypothesized that Wwp2 might be regulated transcriptionally by Sox9. We therefore analysed Wwp2 transcript levels following ectopic expression of Sox9 in two murine cell lines. A marked elevation in Wwp2 expression was observed in the chondrogenic ATDC5 cell line, as well as the mesenchymal C3H10T1/2 cell line, following Sox9 overexpression ( Fig. 2f ). We observed that reduction in endogenous Sox9 levels in ATDC5 cells by Sox9-specific short hairpin RNAs (shRNAs) also led to reductions in Wwp2 levels ( Fig. 2g ). No changes in the expression of the Nedd4-like E3 ligases Smurf1 and Smurf2 were observed in cells containing the Sox9-specific shRNA constructs ( Fig. 2g ). We next performed chromatin immunoprecipitation using an anti-Sox9 antibody to determine if Sox9 could bind to the Wwp2 promoter. Scanning both the promoter and intronic regions of the Wwp2 gene for Sox9-binding sites, we identified a peak representing Sox9 binding an intronic region of Wwp2 between exons 4 and 5 ( Supplementary Information, Fig. S2 ). A control IgG antibody showed no significant enrichment of this segment, indicating that Sox9 is specifically bound at this genomic region ( Fig. 2h ). We next generated a luciferase reporter construct in which the promoter contains the 800 base pair fragment of the Wwp2 intron including the Sox9-binding region. Co-transfection of Sox9 with this reporter construct resulted in marked elevation in luciferase activity ( Fig. 2i ). Interestingly, regulation of Wwp2 by this intronic element seems to be specific for Sox9, as ectopic expression of Sox6, another Sry-box-containing protein, did not activate this reporter construct ( Fig. 2i ). Collectively, these data suggest that Sox9 regulates the cartilaginous expression of Wwp2.
Given that Wwp2 is an E3 ligase, it probably regulates craniofacial patterning through ubiquitylation of specific target proteins. The WW domain of Wwp2 mediates substrate interaction through the binding of a PPxY motif in target proteins. We therefore sought to determine if proteins known to influence craniofacial patterning contain a PPxY motif. From this analysis, we identified this motif in three proteins reported to regulate craniofacial development: Gsc 7-10 , Hand2 and HoxA2 11, 12 . We questioned if Wwp2 could interact with and promote ubiquitylation of these proteins. Immunoprecipitation of Myc epitope-tagged Wwp2 followed by western blotting revealed that Wwp2 interacts with the homeobox protein Gsc but not with another homeobox protein HoxA2 ( Fig. 3a ; Supplementary  Information, Fig. S3 ). We further established that Gsc and Wwp2 could interact physically, through in vitro interaction assays using recombinant fragments of these proteins. We detected a specific interaction between Gsc and the WW domain of Wwp2 (Fig. 3b ). Additional analyses revealed that Wwp2 associates with Gsc through an N-terminal fragment of Gsc that contains the PPxY motif ( Fig. 3c) . Given that the PPxY motif in Gsc is conserved across multiple species ( Supplementary Information, Fig. S3 ), we investigated if this motif is required for its interaction with Wwp2. Mutation of the PPGY motif in Gsc to AAGY or PPGA abolished its interaction with the WW domain of Wwp2 (Fig. 3d ). Finally, analysis of the subcellular distribution of Wwp2 and Gsc by immunofluoresence in ATDC5 cells revealed a nuclear colocalization of these proteins, suggesting that Wwp2 could control craniofacial development in part through its ubiquitylation of Gsc ( Fig.3e ).
To determine if the interaction between these two proteins results in the ubiquitylation of Gsc, we transfected 293T cells with His-ubiquitin, Flag-Gsc and Myc-Wwp2. Western blot analysis of the purified ubiquitylated proteins using an anti-Flag antibody revealed that co-transfection of nature cell biology VOLUME 13 | NUMBER 1 | JANUARY 2011 6 1
Wwp2 resulted in ubiquitylation of Gsc, whereas no ubiquitylation of Gsc was observed in the absence of Wwp2 (Fig. 3f) . A functionally inert Wwp2, in which the active Cys residue was mutated to Ala, could not promote ubiquitylation of Gsc ( Fig. 3g ). To establish that Wwp2 ubiquitylates Gsc directly, through in vitro ubiquitylation reactions, we used purified Gsc and recombinant Wwp2, as well as the recombinant ubiquitin-activating E1 enzyme UBE1 and recombinant E2 ubiquitin ligase UbcH7. Significant ubiquitylation of Gsc was observed during in vitro reactions containing Wwp2, E1 and E2 enzymes ( Fig. 3h ). Conversely, Gsc could not be ubiquitylated in these in vitro reactions lacking any one component (Fig. 3h ). These data demonstrate that Wwp2 ubquitylates Gsc through a direct association with this protein.
Ubiquitylation of a protein generally results in proteasome-mediated degradation. We therefore evaluated Gsc protein levels following cycloheximide treatment, to determine if Wwp2 augments Gsc turnover.
Interestingly, co-expression of Wwp2 with Gsc in 293T cells did not alter Gsc protein levels (Fig. 4a ). Furthermore, the levels of Gsc protein were similar in cells isolated from the nasal cartilage of wild-type and Wwp2 Gt/Gt mice (Fig. 4b ). These findings led us to pursue the possibility that Gsc was being mono-ubiquitylated by Wwp2, a post-translational modification that does not change protein levels. To address this, we analysed Wwp2-mediated ubiquitylation of Gsc in the presence of a His-ubiquitin construct in which all seven Lys residues were mutated to Arg (Ub-K0). Conjugation of Ub-K0 to a target protein prevents the formation of poly-ubiquitin chains, allowing only mono-ubiquitylation of proteins. Interestingly, the ubiquitylation pattern of Gsc was identical in cells transfected with Wwp2 and the K0-ubiquitin expressing construct, and those transfected with the wild-type ubiquitin construct, demonstrating that Gsc is mono-ubiquitylated at multiple sites (Fig. 4c ). We confirmed that Gsc was being mono-ubiquitylated by Wwp2 through in vitro ubiquitylation assays that used purified Gsc, Flag-epitope-tagged Gsc expression construct reveals colocalization of these proteins in the nucleus. Scale bar, 10 μm (f) Analysis of Gsc ubiquitylation was performed in 293T cells transfected with Flag-Gsc, Myc-Wwp2 and His-epitope-tagged ubiquitin. Ubiquitylated Flag-Gsc proteins were detected in cells by precipitating ubiquitylated proteins from denatured lysates with Ni-NTA-agarose, followed by western blot analysis with an anti-Flag antibody. (g) Additional Gsc ubiquitylation experiments were conducted as described in f, using either wild-type (WT) Wwp2 or functionally inert Wwp2 harbouring a Cys to Ala mutation.(h) In vitro ubiquitylation of Gsc was performed using Flag-Gsc purified from 293T cells transfected with Flag-Gsc. Flag-Gsc was incubated with recombinant Wwp2, His-ubiquitin, UBE1 and Ubch7. Reactions were then subjected to western blot analysis with an anti-Flag antibody to detect Gsc proteins. Uncropped images of blots are shown in Supplementary Information, Fig.S7 .
recombinant Wwp2 and ubiquitin-K0 proteins, resulting in a pattern of Gsc ubiquitylation similar to wild-type ubiquitin (Fig. 4d) .
Mono-ubiquitylation of transcription factors has been shown to alter their ability to activate gene transcription. We investigated if Wwp2mediated mono-ubiquitylation alters the transcriptional activity of Gsc. Regulation of transcription factor activity by ubiquitylation has been suggested to be promoter-specific. Therefore, we initially performed gene reporter assays where Wwp2 was co-transfected in cells with Gsc fused to a GAL4 DNA-binding domain, along with a GAL4-responsive luciferase reporter (Fig. 4e ). Co-transfection of increasing amounts of Wwp2 led to increased Gsc-driven luciferase reporter expression in a concentration-dependent manner (Fig. 4f) . These results indicate that Wwp2 augments the transcription activity of Gsc.
Analysis of Wwp2 and Gsc expression by in situ hybridization of E18.5 embryos revealed that these two genes were co-expressed in several tissues, including the nasal cartilage ( Supplementary Information, Fig. S4 ). To identify genes regulated by Wwp2-mono-ubiquitylated Gsc that may influence craniofacial patterning, we performed gene expression analysis of cells isolated from the nasal cartilage of wild-type and Wwp2 GT/GT neonatal mice. A number of candidate genes implicated in craniofacial patterning were found to be dysregulated in Wwp2-null cells. To establish which of these genes is directly regulated by Wwp2, we examined their expression in nasal cartilage cells infected with control or Wwp2expressing lentivirus ( Supplementary Information, Fig. S4 ). One gene identified that was of particular interest was Sox6, a factor involved in cartilage biology 13, 14 . Evaluation of Sox6 levels by in situ hybridization of wild-type and Wwp2 GT/GT skulls revealed decreased Sox6 levels in Wwp2 GT/GT mice, confirming our in vitro observations (Fig. 5a ). Levels of the osteoblast marker Col1a1, which was used as a control, were similar in wild-type and Wwp2 GT/GT sections (Fig. 5a ). Infection of wild-type nasal cartilage cells with Wwp2-expressing lentivirus resulted in elevation of Sox6 levels, indicating that Wwp2 can influence Sox6 expression ( Fig. 5b) . Interestingly, Sox6 expression was not induced when cells were infected with a lentivirus expressing a mutant of Wwp2 that is unable to ubiquitylate target proteins (Fig. 5b) .
Our results suggest that Wwp2 augments expression of Sox6 through its function as an E3 ligase. We sought to determine if Wwp2-mediated mono-ubiquitylation of Gsc is required for optimal expression of Sox6. We explored if Gsc could regulate the expression of Sox6. Indeed, infection of both the ATDC5 and C3H10T1/2 cell with Gsc-expressing lentivirus led to increased Sox6 transcript levels ( Supplementary  Information, Fig. S5 ). To determine if ubiquitylation of Gsc is important for its transcriptional control of Sox6, we generated a series of Gsc protein mutants where each individual Lys residue, as well as different combination of Lys residues, was mutated to Arg. Ubiquitin is conjugated to the Lys ε-amino group of the targeted protein, therefore mutation of the critical Lys residues in Gsc should result in hypo-ubiquitylation of this proteins. From this analysis, we identified three individual Lys residues in Gsc (K219R, K231R, K234R) that, when mutated to Arg (Gsc K3R ), led to a marked reduction in the level of Wwp2-mediated ubiquitylation (Fig. 5c ). Although these mutations in Gsc affected its ability to be ubiquitylated, they did not alter protein levels (Fig. 5c ). We next examined if the reduced ubiquitylation of Gsc K3R correlated with a decrease in transcriptional activity. For this, we infected primary cartilage cells with lentivirus expressing Gsc WT or the Gsc K3R mutant. A marked reduction in the expression of Sox6 levels was observed in cells Supplementary Information, Fig.S7. transduced with the Gsc K3R lentivirus, compared with cells infected with the Gsc WT (Fig. 5d ).
To confirm that Gsc regulates Sox6 expression directly, we attempted to identify the region of the Sox6 promoter that is bound by Gsc. Transfection of a Gsc-expression construct led to a concentration-dependent increase in the expression of a reporter construct that contained a 2.4-kb region of the Sox6 promoter (Fig. 5e ). To identify Gsc-binding sites in the Sox6 promoter, a series of luciferase-reporters containing truncated fragments of the Sox6 promoter were generated and retested. We found that Gsc expression had no effect on (-136)Sox6pro-luc, whereas it could induce expression of the (-187)Sox6pro-luc construct ( Supplementary Information,  Fig. S6 ). We confirmed that Gsc could interact with this region of DNA through oligonucleotide binding assays using the -187 to -136 region of the Sox6 promoter ( Fig. 5f) . As a control, the region (-235 to -185) and (-136 to -87) of the Sox6 promoter showed a marked reduction in Gsc binding (Fig. 5f ). The ability of the Gsc K3R mutant to induce expression of these reporter constructs was significantly impaired (Fig. 5g) . Lastly, we asked if Gsc could induce Sox6 expression in the absence of Wwp2 by analysing Sox6 expression levels in nasal cartilage cells isolated from wild-type or Wwp2 GT/GT mice transduced with control lentivirus or a Gsc-expressing lentivirus. Infection of wild-type nasal cartilage cells with Gsc-expressing lentivirus led to a marked increased in Sox6 expression ( Fig. 5h) . Strikingly, infection of Wwp2 GT/GT nasal cartilage cells with Gsc-expressing lentivirus failed to induce Sox6 expression ( Fig. 5h) . Supplementary Information, Fig.S7 .
Previous reports demonstrate that Sox9 is required for Sox6 expression in vivo and that co-expression of these two proteins function cooperatively to regulate target genes within chondrocytes 15 . We examined how regulation of Sox6 by Wwp2, downstream of Sox9, fits into this cooperative model. Knockdown of endogenous Sox9 with Sox9-specific shRNA resulted in a significant reduction in Sox6 mRNA levels in wild-type and Wwp2-deficient cells (Supplementary information, Fig. S6 ). These data suggest that Sox9 regulates Sox6 expression in part through a Wwp2indepent pathway, and may explain why the absence of Wwp2 in vivo results in levels of Sox6 that are diminished but not abolished. However, we also observed that induction of Sox6 in Wwp2-deficient cells following ectopic expression of Sox9 is markedly reduced when compared with the Sox6 levels that are induced following ectopic expression of Sox9 in wild-type cells ( Supplementary Information, Fig. S6 ). We interpret these data to suggest that Wwp2 functions downstream of Sox9 during patterning of the craniofacial region to 'fine-tune' temporo-spacial expression of Sox6. Wwp2 achieves this regulation through a unique non-proteolytic mechanism that is required for optimal activity of Gsc transcription factor during craniofacial development (Fig. 5i) . 
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